Paper Details

  1. Home
  2. Paper Details

[Bamifylline in the therapy of asthmatic syndromes. Efficacy and side effects vs delayed-action theophylline anhydride].

Author: AlciatoP, CantoneP A, FicoD, GagliardiniR, PetrellaV

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Slow-release theophylline anhydride and bamiphylline are equally effective in treating bronchial asthma and chronic obstructive bronchial pneumonia, with minimal side effects.
Paper Details　
Original Abstract of the Article :
Two homogeneous groups of 8 patients suffering from bronchial asthma or chronic obstructive bronchial pneumonia were treated with slow release theophylline anhydride or bamiphylline respectively, both products being given orally twice a day. The results showed that both drugs possess a powerful bron...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/2314621

データ提供：米国国立医学図書館（NLM）

Bamifylline vs. Theophylline Anhydride for Asthmatic Syndromes

Asthma is like a desert windstorm, suddenly and unexpectedly sweeping through the airways, making it difficult to breathe. This study explores the effectiveness of bamifylline and slow-release theophylline anhydride in treating asthmatic syndromes. It's like comparing two different types of camels, each with its own strengths and weaknesses, in their ability to navigate the harsh terrain of asthma.

Two Effective Bronchodilators

The study found that both bamifylline and slow-release theophylline anhydride possessed powerful bronchodilatory action, offering relief from the suffocating grip of asthma. It's like finding two different oases, each offering a respite from the desert's harsh conditions. The study concludes that both drugs were well-tolerated, with bamifylline showing a slight advantage in terms of side effects.

Navigating the Desert of Asthma

The study suggests that both bamifylline and slow-release theophylline anhydride are effective options for treating asthma, offering patients different ways to navigate the challenging terrain of this chronic respiratory condition. It's important to find the right camel - the right treatment - that fits your specific needs and helps you navigate the desert with the least amount of discomfort.

Dr.Camel's Conclusion

This study provides valuable insights into the treatment options for asthma, highlighting the effectiveness of both bamifylline and slow-release theophylline anhydride. It's a reminder that there are often multiple paths through the desert of asthma, and finding the right one for you can lead to greater comfort and ease in managing this chronic condition.
Date :
  1. Date Completed 1990-04-19
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

2314621

DOI: Digital Object Identifier

2314621

Related Literature

Article Analysis
・Side Effects of theophylline
SNS
PICO Info
in preparation
Languages

Italian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.